response assessment

You have access
Follicular Lymphoma Treated with First-Line Immunochemotherapy: A Review of PET/CT in Patients Who Did Not Achieve a Complete Metabolic Response in the GALLIUM Study
Sally F. Barrington, Farheen Mir, Tarec Christoffer El-Galaly, Andrea Knapp, Tina G. Nielsen, Denis Sahin, Michael Wenger, Lale Kostakoglu, Judith Trotman and Michel Meignan

Journal of Nuclear Medicine August 1, 2022, 63 (8) 1149-1154; DOI: https://doi.org/10.2967/jnumed.121.262869
You have access
Assessing Response to ¹⁷⁷Lu-PSMA Radioligand Therapy Using Modified PSMA PET Progression Criteria
Kerstin Michalski, Claudius Klein, Tonio Brüggemann, Philipp T. Meyer, Cordula A. Jilg and Juri Ruf

Journal of Nuclear Medicine December 1, 2021, 62 (12) 1741-1746; DOI: https://doi.org/10.2967/jnumed.120.260836
You have access
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen–Targeted ¹⁸F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide
Katherine A. Zukotynski, Urban Emmenegger, Sebastien Hotte, Anil Kapoor, Wei Fu, Amanda L. Blackford, John Valliant, François Bénard, Chun K. Kim, Mark C. Markowski, Mario A. Eisenberger, Emmanuel S. Antonarakis, Kenneth J. Pienta, Michael A. Gorin, Matthew Lubanovic, Jihyun Kim, Martin G. Pomper, Steve Y. Cho and Steven P. Rowe

Journal of Nuclear Medicine October 1, 2021, 62 (10) 1430-1437; DOI: https://doi.org/10.2967/jnumed.120.259069
You have access
Treatment Monitoring of Immunotherapy and Targeted Therapy Using ¹⁸F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial Experiences
Norbert Galldiks, Diana S.Y. Abdulla, Matthias Scheffler, Fabian Wolpert, Jan-Michael Werner, Martin Hüllner, Gabriele Stoffels, Viola Schweinsberg, Max Schlaak, Nicole Kreuzberg, Jennifer Landsberg, Philipp Lohmann, Garry Ceccon, Christian Baues, Maike Trommer, Eren Celik, Maximilian I. Ruge, Martin Kocher, Simone Marnitz, Gereon R. Fink, Jörg-Christian Tonn, Michael Weller, Karl-Josef Langen, Jürgen Wolf and Cornelia Mauch

Journal of Nuclear Medicine April 1, 2021, 62 (4) 464-470; DOI: https://doi.org/10.2967/jnumed.120.248278
You have access
Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point ¹⁸F-FDG PET/CT Imaging in Patients with Advanced Melanoma
Steve Y. Cho, Evan J. Lipson, Hyung-Jun Im, Steven P. Rowe, Esther Mena Gonzalez, Amanda Blackford, Alin Chirindel, Drew M. Pardoll, Suzanne L. Topalian and Richard L. Wahl

Journal of Nuclear Medicine September 1, 2017, 58 (9) 1421-1428; DOI: https://doi.org/10.2967/jnumed.116.188839
You have access
Quantitation of Cancer Treatment Response by ¹⁸F-FDG PET/CT: Multicenter Assessment of Measurement Variability
Joo Hyun O, Heather Jacene, Brandon Luber, Hao Wang, Minh-Huy Huynh, Jeffrey P. Leal and Richard L. Wahl

Journal of Nuclear Medicine September 1, 2017, 58 (9) 1429-1434; DOI: https://doi.org/10.2967/jnumed.117.189605
You have access
Midtreatment ¹⁸F-FDG PET/CT Scan for Early Response Assessment of SMILE Therapy in Natural Killer/T-Cell Lymphoma: A Prospective Study from a Single Center
Pek-Lan Khong, Bingsheng Huang, Elaine Yuen Phin Lee, Winnie Kit Sum Chan and Yok-Lam Kwong

Journal of Nuclear Medicine June 1, 2014, 55 (6) 911-916; DOI: https://doi.org/10.2967/jnumed.113.131946
You have access
Response Assessment Using ¹⁸F-FDG PET Early in the Course of Radiotherapy Correlates with Survival in Advanced-Stage Non–Small Cell Lung Cancer
Wouter van Elmpt, Michel Öllers, Anne-Marie C. Dingemans, Philippe Lambin and Dirk De Ruysscher

Journal of Nuclear Medicine October 1, 2012, 53 (10) 1514-1520; DOI: https://doi.org/10.2967/jnumed.111.102566

Main menu

User menu

Search

response assessment